Clinical Trials on Atherosclerotic Plaque in Sweden

Total 69 results

Lund University
The Swedish Research Council; Region Skane; Swedish Heart Lung Foundation; Swedish... and other collaborators

Recruiting

Carotid Plaque Imaging Project (CPIP) (CPIP)

Atherosclerosis | Atherosclerotic Plaque

Sweden
Nilminie Rathnayake
University of Helsinki

Not yet recruiting

Antibacterial Photodynamic Therapy in the Management of Peri-implantitis

Peri-Implantitis | Plaque, Dental

Sweden
NHS National Waiting Times Centre Board
Stanford University; Catharina Ziekenhuis Eindhoven; Onze Lieve Vrouw Hospital; Brno University Hospital and other collaborators

Completed

Fractional Flow Reserve (FFR) Versus Instant Wave-Free Ratio (iFR)

Coronary Artery Disease | Plaque, Atherosclerotic

Netherlands, United States, Czech Republic, Belgium, Sweden
Koite Health Oy
Helsinki University Central Hospital; University of Helsinki

Recruiting

Regular Home Use of Dual-light Photodynamic Therapy on Oral Health in Adolescents Undergoing Fixed Orthodontic Treatment

Plaque, Dental | Orthodontic Appliance Complication | Gingival Inflammation

Sweden
Biocool AB

Completed

Investigation With BiopH+Psoriasis Medical Bath in Subject With Mild to Moderate Plaque Psoriasis.

Plaque Psoriasis

Sweden
Malmö University
Skane University Hospital

Recruiting

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.

Oral Lichen Planus

Sweden
Koite Health Oy
Karolinska Institutet; University of Helsinki

Withdrawn

Regular Antibacterial Photodynamic Therapy on Oral Hygiene in the Elderly 24-hour Care

Plaque | Inflamed Gums | Dryness Oral

Sweden
Amgen

Active, not recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Atherosclerotic Cardiovascular Disease

United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
Malmö University
Lund University

Completed

The Oral Microbiota as Reservoir for Systemic Opportunistic Pathogens

Pulmonary Disease, Chronic Obstructive | Dental Plaque | COPD Exacerbation

Sweden
Dalarna County Council, Sweden

Terminated

Intra and Extra Oral Inspection of Oral Mucosa

Oral Leukoplakia | Oral Lichen Planus | Erythroplakia

Sweden
AstraZeneca

Completed

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

Atherosclerosis | Inflammatory Activity in Coronary Arteries

Sweden
Amgen

Completed

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Atherosclerotic Cardiovascular Disease

Canada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
Region Skane

Completed

Effects of Fish Oil on Platelet Function and Coagulation (FOILP)

Atherosclerosis | Surgery | Platelet Aggregation, Spontaneous

Sweden
Novartis Pharmaceuticals

Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease

United States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
Novartis Pharmaceuticals

Active, not recruiting

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Atherosclerotic Cardiovascular Disease

United States, China, South Africa, Spain, Austria, Belgium, Croatia, Estonia, Hungary, Taiwan, Turkey, Netherlands, Italy, Australia, Czechia, Denmark, France, Israel, Korea, Republic of, Thailand, Argentina, Bulgaria, Greece, Romania, Sloveni... and more
AstraZeneca

Completed

Effects of Crestor on Inflammation of Atherosclerotic Plaques

Atherosclerosis | Inflammatory Activity in Carotid Arteries

Sweden
Göteborg University

Recruiting

Inflammation in Vascular Disease (REBEL)

Vascular Diseases | Atherosclerosis

Sweden
Karolinska Institutet

Completed

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects (Rebuild)

Diabetes | Atherosclerosis | Restenosis

Sweden
Halla Halldorsdottir
Karolinska Institutet

Completed

Heparin-Binding Protein and Heparins (HepHep)

Cardiovascular Diseases | Vascular Disease, Peripheral | Thromboprophylaxis

Sweden
Jonas Malmstedt

Completed

HRQoL Among Patients Amputated Due to Peripheral Arterial Disease

Quality of Life | Peripheral Arterial Disease | Amputation | Prosthesis User

Sweden
Skane University Hospital

Completed

DEB ( Drug Eluting Balloon) in Crural Arteries and Critical Limb Ischemia

Peripheral Vascular Diseases

Sweden
Karolinska Institutet

Completed

Classification of Carotid Plaque With Computed Tomography With Fast kVp (Kilovolt Peak)-Switching Technique

Atherosclerosis | Carotid Stenosis

Sweden
Rebecka Hultgren
Karolinska University Hospital; Karolinska Institutet; Sahlgrenska University... and other collaborators

Recruiting

Prospective Case-control Study in Patients With PAA

Quality of Life | Peripheral Arterial Disease | Popliteal Artery Aneurysm

Sweden
Karolinska Institutet

Withdrawn

Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery (HODiVA)

Diabetes | Peripheral Arterial Disease | Arterial Occlusive Disease

Sweden
Uppsala University
Västmanland County Council, Sweden

Completed

Peripheral Artery Disease in Vastmanland (PADVa)

Heart Failure | Peripheral Vascular Diseases | Ventricular Dysfunction

Sweden
Örebro County Council

Completed

Graft Patency as a Predictor of Health-related Quality of Life.

Atherosclerosis | Ischemic Heart Disease

Sweden
Sahlgrenska University Hospital, Sweden
Uppsala University; The Swedish Research Council; Swedish Heart Lung Foundation; The Swedish National Registry for Vascular Surgery

Active, not recruiting

Swedish Drug-elution Trial in Peripheral Arterial Disease (SWEDEPAD)

Peripheral Arterial Disease | Intermittent Claudication | Critical Limb Ischemia

Sweden
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events (SANTORINI)

Cardiovascular Diseases | Dyslipidemia | Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

Finland, Netherlands, Spain, Belgium, Sweden, Austria, United Kingdom, Switzerland, Denmark, France, Germany, Portugal, Italy, Ireland
Karolinska University Hospital
Karolinska Institutet

Completed

Interstitial Fluid in the Development of Cardiovascular Disease

Atherosclerosis | Type2 Diabetes

Sweden
Vastra Gotaland Region

Active, not recruiting

Effect of Smoking on Pain and Atherosclerosis in Patients With Rheumatoid Arthritis (RAsmo)

Pain | Rheumatoid Arthritis | Atherosclerosis

Sweden
Sahlgrenska University Hospital, Sweden
Karolinska University Hospital; Skane University Hospital; Karlstad Central Hospital and other collaborators

Active, not recruiting

An E-health Intervention for Patients With Peripheral Artery Disease (I-PAD)

Intermittent Claudication

Sweden
Sanofi
Regeneron Pharmaceuticals

Completed

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Atherosclerotic Cardiovascular Disease

China, Hong Kong, Austria, Bulgaria, Norway, Peru, France, Japan, Spain, Lithuania, Philippines, Israel, Belgium, Croatia, Poland, Hungary, Chile, Mexico, Latvia, Singapore, Switzerland, Colombia, Greece, Ukraine, Turkey, Finland, United States and more
Novartis Pharmaceuticals

Completed

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis (STEPin)

Plaque Psoriasis

Spain, United Kingdom, Estonia, Germany, Bulgaria, Finland, Hungary, Poland, Argentina, Canada, Denmark, Switzerland, Sweden
Sahlgrenska University Hospital, Sweden

Enrolling by invitation

Agreement Study on AI-assisted Smartphone-based Monitoring Tool for Difficult-to-heal Ischemic Leg Ulcers

Chronic Limb-Threatening Ischemia

Sweden
Uppsala University
Västmanland County Council, Sweden

Completed

Vastmanland Myocardial Infarction Study (VaMIS) (VaMIS)

Diabetes | Peripheral Artery Disease | Acute Myocardial Infarction

Sweden
Eli Lilly and Company

Completed

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)

Plaque Psoriasis

Germany, Spain, Belgium, France, Hungary, Austria, Canada, Italy, Netherlands, Poland, Sweden, Switzerland, United Kingdom
Medtronic Endovascular

Completed

EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study

Peripheral Arterial Diseases

Germany
LEO Pharma

Terminated

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab (COBRA)

Psoriasis | Plaque Psoriasis | Psoriasis Vulgaris

Belgium, Germany, Italy, Spain, Denmark, Austria, France, Greece, Switzerland, United Kingdom, Netherlands, Sweden
Bayer
Janssen, LP

Completed

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid (XATOA)

Atherosclerosis

Germany, Argentina, Brazil, Canada, Denmark, Israel, Korea, Republic of, Lebanon, Luxembourg, Mexico, Norway, Russian Federation, Slovenia, Sweden, Switzerland, Thailand, United Arab Emirates, United Kingdom
Abbott

Completed

Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE)

Chronic Plaque Psoriasis

Belgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
AbbVie (prior sponsor, Abbott)

Completed

Documentation of Humira in Psoriasis Patients in Routine Clinical Practice (LOTOS)

Moderate to Severe Plaque Psoriasis

Germany
AbbVie (prior sponsor, Abbott)

Completed

Open Label Continuation Study in Moderate to Severe Psoriasis

Moderate to Severe Plaque Psoriasis

United States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

Plaque Psoriasis Efficacy and Safety With Secukinumab (OPTIMISE)

Plaque Psoriasis

Germany, Belgium, Spain, Croatia, Czechia, Greece, Hungary, Russian Federation, Netherlands, Austria, France, Switzerland, Israel, United Kingdom, Italy, Lithuania, Sweden, Bulgaria, Denmark, Finland, Portugal, Slovakia, Poland, Latvia
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis (FIXTURE)

Chronic Plaque Psoriasis

Germany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
Veryan Medical Ltd.

Unknown

Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D (MIMICS-3D)

Peripheral Arterial Disease

Netherlands, Sweden, Germany, Belgium
AbbVie

Completed

Chronic Plaque Psoriasis (Ps) Registry

Chronic Plaque Psoriasis

United States, Austria, Canada, Czechia, Denmark, France, Germany, Greece, Ireland, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom
Sanofi
Bristol-Myers Squibb

Completed

CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease

Arterial Occlusive Diseases

France, Spain, Italy, Belgium, Germany, Hungary, Poland, Australia, Austria, Netherlands, Sweden, United Kingdom, Finland, Switzerland
Novartis Pharmaceuticals

Completed

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Moderate to Severe Plaque-type Psoriasis

Germany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
AbbVie

Active, not recruiting

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis (VALUE)

Chronic Plaque Psoriasis

Argentina, Australia, Austria, Canada, Colombia, Czechia, France, Germany, Hungary, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
C. R. Bard
Cromsource

Completed

FLUENCY® PLUS in the Treatment of Peripheral Artery Disease

Vascular Diseases, Peripheral

Germany, Poland

3

Subscribe